1.0Cloudbreak Pharma, Inc.https://cloudbreakpharma.com/zhastraelemhttps://cloudbreakpharma.com/zh/author/astraelem/rich600338<blockquote class="wp-embedded-content" data-secret="qtknAb28bx"><a href="https://cloudbreakpharma.com/zh/about/elizabeth-capan/">Elizabeth Capan</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://cloudbreakpharma.com/zh/about/elizabeth-capan/embed/#?secret=qtknAb28bx" width="600" height="338" title="《 Elizabeth Capan 》—Cloudbreak Pharma, Inc." data-secret="qtknAb28bx" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://cloudbreakpharma.com/wp-includes/js/wp-embed.min.js </script>Elizabeth Capan, J.D. Chief Patent Officer Elizabeth Capan joined Cloudbreak Pharma as the Chief Patent Officer in September 2022. She has over 10 years of experiences in global IP strategy development and execution, patent applications and prosecutions. Ms. Capan helped companies recognise, nurture and protect innovations, and provided assistance in IP portfolio management and strategic […]https://cloudbreakpharma.com/wp-content/uploads/2026/03/Elizabeth-Capan-Headshot-2026-1024x1024.jpg